Ocular microinjection platform for non-surgical, targeted delivery of drugs and proteins into the suprachoroidal space
There’s no risk. Start your trial today to see profiles of Clearside Biomedical (NASDAQ:CLSD) plus 5267 other startups.
Start Free 7 Day Trial Now